Cargando…

Advanced glycation end products (AGEs) promote melanogenesis through receptor for AGEs

Accumulation of advanced glycation end products (AGEs) is linked with development or aggravation of many degenerative processes or disorders, including aging and atherosclerosis. AGEs production in skin cells is known to promote stiffness and loss of elasticity through their buildup in connective ti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Eun Jung, Kim, Ji Young, Oh, Sang Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904211/ https://www.ncbi.nlm.nih.gov/pubmed/27293210 http://dx.doi.org/10.1038/srep27848

Ejemplares similares

Advanced glycation end products regulate the receptor of AGEs epigenetically
por: Wu, Xiaoqing, et al.
Publicado: (2023)

Dietary Advanced Glycation End Products and Aging
por: Luevano-Contreras, Claudia, et al.
Publicado: (2010)

Advanced Glycation End Products (AGEs), Receptor for AGEs, Diabetes, and Bone: Review of the Literature
por: Asadipooya, Kamyar, et al.
Publicado: (2019)

Abstract: Perceived Facial Aging: The Role of AGES (Advanced Glycation End Products)
por: Lee, Jonathan Y., et al.
Publicado: (2017)

Advanced Glycation End-Products in Skeletal Muscle Aging
por: Olson, Lucas C., et al.
Publicado: (2021)

Advanced Glycation End-Products (AGEs): Formation, Chemistry, Classification, Receptors, and Diseases Related to AGEs
por: Twarda-Clapa, Aleksandra, et al.
Publicado: (2022)

The anti-tumor effects of evodiamine on oral squamous cell carcinoma (OSCC) through regulating advanced glycation end products (AGE) / receptor for advanced glycation end products (RAGE) pathway
por: Ren, Liuyang, et al.
Publicado: (2021)

Activation of Akt by Advanced Glycation End Products (AGEs): Involvement of IGF-1 Receptor and Caveolin-1
por: Yang, Su-Jung, et al.
Publicado: (2013)

Advanced glycation end products: Key players in skin aging?
por: Gkogkolou, Paraskevi, et al.
Publicado: (2012)

A Role for Advanced Glycation End Products in Molecular Ageing
por: Zgutka, Katarzyna, et al.
Publicado: (2023)

The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs
por: Xue, Jing, et al.
Publicado: (2014)

Knockout of receptor for advanced glycation end‐products attenuates age‐related renal lesions
por: Teissier, Thibault, et al.
Publicado: (2019)

Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis
por: Scavello, Francesco, et al.
Publicado: (2021)

Effects of Advanced Glycation End Products on Differentiation and Function of Osteoblasts and Osteoclasts
por: Park, So Young, et al.
Publicado: (2021)

The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer’s Disease
por: Ko, Shun-Yao, et al.
Publicado: (2015)

Dietary Advanced Glycation End Products: Their Role in the Insulin Resistance of Aging
por: Portero-Otin, Manuel, et al.
Publicado: (2023)

Advanced glycation end products (AGEs) and their receptor (RAGE) induce apoptosis of periodontal ligament fibroblasts
por: Li, D.X., et al.
Publicado: (2014)

Modulation of soluble receptor for advanced glycation end-products (RAGE) isoforms and their ligands in healthy aging
por: Scavello, Francesco, et al.
Publicado: (2019)

Role of Advanced Glycation End-Products and Other Ligands for AGE Receptors in Thyroid Cancer Progression
por: Bronowicka-Szydełko, Agnieszka, et al.
Publicado: (2021)

Oxidative Stress and Advanced Lipoxidation and Glycation End Products (ALEs and AGEs) in Aging and Age-Related Diseases
por: Moldogazieva, Nurbubu T., et al.
Publicado: (2019)

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
por: Dozio, Elena, et al.
Publicado: (2020)

Critical Appraisal of Advanced Glycation End Products (AGEs) and Circulating Soluble Receptors for Advanced Glycation End Products (sRAGE) as a Predictive Biomarkers for Cardiovascular Disease in Hemodialysis Patients
por: Assiri, Adel M. A., et al.
Publicado: (2018)

The Receptor for Advanced Glycation End Products (RAGE) and the Lung
por: Buckley, Stephen T., et al.
Publicado: (2010)

Advanced glycation end product (AGE) modified proteins in tears of diabetic patients
por: Zhao, Zhenjun, et al.
Publicado: (2010)

The Contribution of Advanced Glycation End product (AGE) accumulation to the decline in motor function
por: Drenth, Hans, et al.
Publicado: (2016)

Phagocytosis of Advanced Glycation End Products (AGEs) in Macrophages Induces Cell Apoptosis
por: Gao, Yuan, et al.
Publicado: (2017)

Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
por: Yamagishi, Sho-ichi, et al.
Publicado: (2018)

In Vitro Methodologies to Study the Role of Advanced Glycation End Products (AGEs) in Neurodegeneration
por: Chrysanthou, Marialena, et al.
Publicado: (2022)

The Role of Advanced Glycation End Products in Diabetic Vascular Complications
por: Rhee, Sang Youl, et al.
Publicado: (2018)

Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol
por: Xu, Lei, et al.
Publicado: (2016)

Advanced Glycation End Products (AGEs) and Chronic Kidney Disease: Does the Modern Diet AGE the Kidney?
por: Fotheringham, Amelia K., et al.
Publicado: (2022)

Endogenous Secretory Receptor for Advanced Glycation End Products Protects Endothelial Cells from AGEs Induced Apoptosis
por: Yang, Guomin, et al.
Publicado: (2018)

Receptor Mediated Effects of Advanced Glycation End Products (AGEs) on Innate and Adaptative Immunity: Relevance for Food Allergy
por: Briceno Noriega, Daniela, et al.
Publicado: (2022)

The expression of the receptor for advanced glycation end-products (RAGE) in RA-FLS is induced by IL-17 via Act-1
por: Heo, Yu-Jung, et al.
Publicado: (2011)

Assessment of Advanced Glycation End Products and Receptors and the Risk of Dementia
por: Chen, Jinluan, et al.
Publicado: (2021)

Pharmacologic Approaches Against Advanced Glycation End Products (AGEs) in Diabetic Cardiovascular Disease
por: Nenna, Antonio, et al.
Publicado: (2015)

Advanced Glycation End Products (AGEs): Biochemistry, Signaling, Analytical Methods, and Epigenetic Effects
por: Perrone, Anna, et al.
Publicado: (2020)

Relationships between advanced glycation end products (AGEs), vasoactive substances, and vascular function
por: Matsumoto, Takayuki, et al.
Publicado: (2022)

Serum Fluorescent Advanced Glycation End (F-AGE) products in gestational diabetes patients
por: Lobo, João Paulo, et al.
Publicado: (2017)

Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease
por: Dozio, Elena, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_eqjmojlcsub4bj4mng2mrg2r7r